Table 2.
Association of BCL6 protein expression with clinicopathological parameters from breast cancer patients
|
Parameter |
n
|
BCL6 protein |
|
|---|---|---|---|
| Positive, n (%) | P value | ||
| Age (years) |
|
||
| ≤ 35 |
6 |
2 (33.3) |
0.253 |
| 35-55 |
84 |
31 (36.9) |
|
| > 55 |
37 |
8 (21.6) |
|
| Tumor size (cm) |
|
||
| ≤ 2 |
44 |
7 (15.9) |
0.004 |
| >2 |
83 |
34 (41.0) |
|
| Lymph node metastasis |
|
||
| No |
58 |
13 (22.4) |
0.029 |
| Yes |
69 |
28 (40.6) |
|
| Grade |
|
||
| I |
28 |
4 (14.3) |
0.003 |
| II |
75 |
23 (30.7) |
|
| III |
24 |
14 (58.3) |
|
| Stage |
|
|
|
| I |
28 |
3 (10.7) |
0.006 |
| II - III |
99 |
38 (38.4) |
|
| Estrogen receptor |
|
|
|
| Negative |
56 |
22 (39.3) |
0.134 |
| Positive |
71 |
19 (26.8) |
|
| Progesterone receptor |
|
||
| Negative |
64 |
22 (34.4) |
0.611 |
| Positive |
63 |
19 (30.2) |
|
| c-erbB-2 |
|
||
| low |
93 |
32 (34.4) |
0.397 |
| high |
34 |
9 (26.5) |
|
| Ki67 |
|
|
|
| ≤50% |
50 |
8 (16.0) |
0.002 |
| >50% | 77 | 33 (42.9) | |
Values in bold are significant (P < 0.05).